Vanta Bioscience Limited (VANTABIO.BO)
INR 42.57
(0.0%)
INR 42.57
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 97.22 Million | 58.28 Million | 93.94 Million | 98.15 Million | 137.53 Million | 120.8 Million |
| Cost of Revenue | 90.1 Million | 71.62 Million | 47.98 Million | 46.61 Million | 75.35 Million | 53.43 Million |
| Gross Profit | 7.12 Million | -13.33 Million | 45.96 Million | 51.54 Million | 62.18 Million | 67.36 Million |
| Operating Expenses | 38.95 Million | 37.3 Million | 24.43 Million | 24.06 Million | 30.38 Million | 37.21 Million |
| Selling, General and Administrative Expenses | 38.95 Million | 36.86 Million | 23.41 Million | 23.8 Million | 30.31 Million | 37.02 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -446.59 Thousand | -1.02 Million | -260.29 Thousand | -70.01 Thousand | -192.92 Thousand |
| Cost and Expenses | 129.06 Million | 108.93 Million | 72.41 Million | 70.67 Million | 105.73 Million | 90.64 Million |
| Operating Income | -31.83 Million | -50.64 Million | 21.52 Million | 27.47 Million | 31.8 Million | 30.15 Million |
| Interest Expense | 57.48 Million | 58.85 Million | 23.46 Million | 21.31 Million | 19.48 Million | 16.88 Million |
| Income Tax Expense | -2.2 Million | 1.81 Million | 936.95 Thousand | 1.4 Million | 3.29 Million | 4.05 Million |
| Earnings before Tax | -88.26 Million | -102.62 Million | 2.28 Million | 5.89 Million | 13.41 Million | 11.03 Million |
| Net Income | -23.15 Million | -64.8 Million | 882.07 Thousand | 4.49 Million | 10.04 Million | 6.96 Million |
| Earnings Per Share Basic | -3.67 | -10.27 | 0.14 | 0.71 | 1.59 | 1.10 |
| Earnings Per Share Diluted | -3.67 | -10.27 | 0.14 | 0.71 | 1.59 | 1.10 |
| Weighted Average Shares Outstanding | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million |
| Gross Margin | 0.07 | -0.23 | 0.49 | 0.53 | 0.45 | 0.56 |
| EBIT Margin | 0.15 | -0.41 | 0.37 | 0.41 | 0.32 | 0.31 |
| Profit Margin | -0.24 | -1.11 | 0.01 | 0.05 | 0.07 | 0.06 |
| EBITDA | 14.19 Million | -17.06 Million | 38.91 Million | 39.72 Million | 44.79 Million | 35.02 Million |
| Earnings Before Tax Margin | -0.33 | -0.87 | 0.23 | 0.28 | 0.23 | 0.25 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 97.22 Million | 35.47 Million | 61.75 Million | 34.52 Million | 58.28 Million | 28.23 Million |
| Cost of Revenue | 90.1 Million | 49.9 Million | 40.2 Million | 47.06 Million | 71.62 Million | 28.54 Million |
| Gross Profit | 7.12 Million | -14.43 Million | 21.55 Million | -12.54 Million | -13.33 Million | -308 Thousand |
| Operating Expenses | 38.95 Million | 22.6 Million | 16.35 Million | 19.51 Million | 37.3 Million | 18.27 Million |
| Selling, General and Administrative Expenses | - | 22.6 Million | 16.35 Million | 19.51 Million | - | 18.27 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.06 Million | - | - | - | -446.59 Thousand | - |
| Cost and Expenses | 129.06 Million | 72.5 Million | 56.56 Million | 66.58 Million | 108.93 Million | 46.81 Million |
| Operating Income | -31.83 Million | -37.03 Million | 5.19 Million | -32.05 Million | -50.64 Million | -18.58 Million |
| Interest Expense | 57.48 Million | 28.99 Million | 28.49 Million | 34.03 Million | 58.85 Million | 24.82 Million |
| Income Tax Expense | -2.2 Million | -1.97 Million | -227 Thousand | 879 Thousand | 1.81 Million | 940 Thousand |
| Earnings before Tax | -88.26 Million | -65.26 Million | -23 Million | -59.33 Million | -102.62 Million | -43.29 Million |
| Net Income | -23.15 Million | -17.79 Million | -5.36 Million | -39.2 Million | -64.8 Million | -25.6 Million |
| Earnings Per Share Basic | - | -2.82 | -0.85 | -6.21 | - | -4.06 |
| Earnings Per Share Diluted | - | -2.82 | -0.85 | -6.21 | - | -4.06 |
| Weighted Average Shares Outstanding | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million | 6.31 Million |
| Gross Margin | 0.07 | -0.41 | 0.35 | -0.36 | -0.23 | -0.01 |
| EBIT Margin | - | -0.21 | 0.33 | -0.53 | - | -0.19 |
| Profit Margin | -0.24 | -0.50 | -0.09 | -1.14 | -1.11 | -0.91 |
| EBITDA | - | -7.51 Million | 20.64 Million | -18.46 Million | - | -5.47 Million |
| Earnings Before Tax Margin | -0.33 | -1.04 | 0.08 | -0.93 | -0.87 | -0.66 |
ALMOU
DEEPAKCHEM
AKRIT
ZWELCAST
ICDSLTD
MOGAN